| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |